The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients

Published:2008-10-18 Issue:16 Volume:22 Page:2155-2163
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Gallant Joel E,Winston Jonathan A,DeJesus Edwin,Pozniak Anton L,Chen Shan-Shan,Cheng Andrew K,Enejosa Jeffrey V

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference24 articles.

1. Efficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral naïve patients: a 3-year randomized trial;Gallant;JAMA,2004

2. Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis;Arribas;J Acquir Immune Defic Syndr,2008

3. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection;Squires;Ann Intern Med,2003

4. Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study;Schooley;AIDS,2002

5. Human renal organic anion transporter (hOAT1) and its role in nephrotoxicity of antiviral nucleoside analogs;Cihlar;Nucleos Nulceot Nucleic Acids,2001

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary α 1-microglobulin and β 2-microglobulin as markers of early kidney injury in HIV-positive male patients on tenofovir-based antiretroviral therapy;PLOS ONE;2024-06-17

2. Evaluation of the safety and antiviral efficacy of the tenofovir alafenamide fumarate molecule in immunosuppressed patients;Journal of Health Sciences and Medicine;2022-10-25

3. Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial;BMC Infectious Diseases;2022-07-20

4. Tenofovir alafenamide fumarate;Antiviral Therapy;2022-03-07

5. New onset kidney impairment in a large pre-exposure prophylaxis demonstration project in New South Wales, Australia;AIDS;2021-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3